Enoxaparin 40 mg

DRUG3 trials

Sponsors

Janssen Research & Development, LLC, Peking University People's Hospital, Wolfson Medical Center

Conditions

Arthroplasty, Replacement, KneeCesarean Section SurgeryHypoalbuminemiaNephrotic SyndromePostpartum PeriodVTE (Venous Thromboembolism)

Phase 2

A Study of JNJ-70033093 (BMS-986177) Versus Subcutaneous Enoxaparin in Participants Undergoing Elective Total Knee Replacement Surgery

CompletedNCT03891524

Janssen Research & Development, LLCArthroplasty, Replacement, Knee

Start: 2019-06-17End: 2021-04-06Updated: 2025-03-30

Unknown Phase

Edoxaban Steady-State PK/PD in Adults With Nephrotic Syndrome

Not yet recruitingNCT07116239

Peking University People's HospitalHypoalbuminemia, Nephrotic Syndrome

Start: 2025-09-30End: 2026-02-28Target: 60Updated: 2025-08-11

Rivaroxaban vs Enoxaparin After Cesarean Section: Laboratory Thromboprophylaxis Outcomes

RecruitingNCT07820670

Wolfson Medical CenterCesarean Section Surgery, Postpartum Period, VTE (Venous Thromboembolism)

Start: 2025-12-01End: 2027-12-01Target: 62Updated: 2026-09-15

Related Papers

Milvexian for the Prevention of Venous Thromboembolism

New England Journal of Medicine2021-11-15234 citations